National Guideline Clearinghouse | Optimal systemic therapy for early female breast cancer.
Program in Evidence-based Care: Cancer Care Ontario (CCO)
Optimal systemic therapy for early female breast cancer.
|Eisen A, Fletcher GG, Gandhi S, Mates M, Freedman OC, Dent SF, Trudeau ME, Members of the Early Breast Cancer Systemic Therapy Consensus Panel. Optimal systemic therapy for early female breast cancer. Toronto (ON): Cancer Care Ontario (CCO); 2014 Sep 30. 232 p. (Program in Evidence-Based Care Evidence-Based Series; no. 1-21). [473 references]|
This is the current release of the guideline.
The EVIDENCE-BASED SERIES report, initially the full original Guideline, over time will expand to contain new information emerging from their reviewing and updating activities.
Please visit the Cancer Care Ontario (CCO) Web site for details on any new evidence that has emerged and implications to the guidelines.
This guideline meets NGC's 2013 (revised) inclusion criteria.